StockData
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

PANACEA LIFE SCIENCES HOLDINGS, INC.

Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026

Market cap
$1.15M
P/E (TTM)
–
Dividend yield
–

PANACEA LIFE SCIENCES HOLDINGS, INC. revenue by segment

By business segment

By product or service

By region

From the segment and revenue-disaggregation notes of Panacea Life Sciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.